Sharechat Logo

Kaimai, Fonterra milk supply dispute goes to regulator

Thursday 31st July 2008

Text too small?
A dispute between Kaimai Cheese Co. and Fonterra Cooperative Group over supplies of raw milk for the cheese-maker will be determined by the Commerce Commission.

"The two parties have been unable to agree on terms under which Kaimai is able to access raw milk from Fonterra under the Raw Milk Regulations during the 2008/2009 season," the commission said in a statement.

Kaimai, whose shares trade on the Unlisted market, started operations in January producing a range of European style cheeses under French cheese-maker Philippe Aucher. It counts former Revenue Minister Wyatt Creech as company secretary and currently buys its milk from Open Country Cheese Co., also traded on Unlisted.

In its application to the commission, Kaimai said Fonterra has refused to supply raw milk arguing the cheese-maker isn't an independent processor under the Dairy Industry Restructuring Act 2001 and the Dairy Industry Restructuring (Raw Milk) Regulations 2001.

Kaimai wants to buy about 10 million litres of raw milk from Fonterra though it wants it delivered to Open Country which has a contract to pasteurize the milk. Fonterra says the 10 million litres would count toward Open Country's 50 million litre allocation under the Raw Milk Regulations.

By Jonathan Underhill



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors